Charkes N D, Maurer A H, Siegel J A, Radecki P D, Malmud L S
Radiology. 1987 Aug;164(2):491-4. doi: 10.1148/radiology.164.2.3602391.
Thirty-six patients with a variety of thyroid disorders and eight healthy subjects were studied with T1- and T2-weighted magnetic resonance (MR) imaging. Solid benign nodules, malignant tumors, and inflammatory conditions were not distinguishable by thyroidal MR signal intensity, but almost all patients with Graves disease had a moderate to marked diffuse increase in signal intensity at both settings. Quantitative evaluation showed that in these patients, the thyroid-muscle signal intensity contrast ratio was linearly related to both the serum thyroxine (T4) level and the 24-hour radioactive iodine uptake. In three patients treated with iodine 131, this contrast ratio rose or fell in parallel with the serum T4 level and 24-hour radioactive iodine uptake. Either parenchymal changes or increased vascularity in Graves disease, or both, could produce these findings. In patients without Graves disease, signal intensity was not correlated with serum T4 levels. These findings suggest that MR signal intensity may reflect the activity of the stimulatory process in Graves disease and may therefore be a useful measure of thyroid function in this disorder, with both diagnostic and prognostic value.
对36例患有各种甲状腺疾病的患者和8名健康受试者进行了T1加权和T2加权磁共振(MR)成像研究。实性良性结节、恶性肿瘤和炎症性疾病无法通过甲状腺MR信号强度区分,但几乎所有格雷夫斯病患者在两种成像设置下信号强度均有中度至明显的弥漫性增加。定量评估表明,在这些患者中,甲状腺-肌肉信号强度对比率与血清甲状腺素(T4)水平和24小时放射性碘摄取均呈线性相关。在3例接受131碘治疗的患者中,这种对比率与血清T4水平和24小时放射性碘摄取平行上升或下降。格雷夫斯病中的实质改变或血管增多,或两者兼而有之,均可产生这些结果。在没有格雷夫斯病的患者中,信号强度与血清T4水平无关。这些发现表明,MR信号强度可能反映了格雷夫斯病刺激过程的活性,因此可能是该疾病甲状腺功能的一种有用测量方法,具有诊断和预后价值。